Erratum to Jenny S. Henkel, David R. Beers, Shixiang Wen, Andreana L. Rivera, Karen M. Toennis, Joan E. Appel, Weihua Zhao, Dan H. Moore, Suzanne Z. Powell and Stanley H. Appel (2013) Regulatory T‐lymphocytes mediate amyotrophic lateral sclerosis progression and survival. EMBO Mol Med 5 (1) DOI: 10.1002/emmm.201201544
The phrase “change in AALS score ÷ change in time” appeared as “change in AALS score, change in time”. This error occurred on pages 2, 10 and 14. The correct sentences are printed below.
However, differences were noted when the patients were separated and grouped based on their rate of disease progression at the time of blood collection [rate was determined as the change in AALS score ÷ change in time (months), comparing the initial clinical evaluation with the evaluation performed at the time of blood collection].
To evaluate whether early FoxP3 levels could be used to predict future progression rates, the mRNA levels in leukocytes from the 102 patients obtained early in disease were compared with their rate of progression at the end of the evaluation period [rate was determined as the change in AALS score ÷ change in time (months), comparing the initial evaluation with the evaluation at the end of the 3.5‐year follow‐up period].
Rate was determined as the change in AALS score ÷ change in time, comparing the initial evaluation with the evaluation at the time of collection or with the evaluation at the end of analysis.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
- Copyright © 2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO